These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30096705)

  • 1. A pooled analysis of published, basket trials in cancer medicine.
    Hazim A; Prasad V
    Eur J Cancer; 2018 Sep; 101():244-250. PubMed ID: 30096705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of basket and umbrella trials in oncology: the importance of tissue of origin and molecular target.
    Haslam A; Olivier T; Tuia J; Prasad V
    Eur J Cancer; 2023 Jan; 178():227-233. PubMed ID: 36493558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers.
    Haslam A; Olivier T; Tuia J; Prasad V
    BMC Cancer; 2023 Jan; 23(1):46. PubMed ID: 36639625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
    Tao JJ; Schram AM; Hyman DM
    Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basket trials: From tumour gnostic to tumour agnostic drug development.
    Dittrich C
    Cancer Treat Rev; 2020 Nov; 90():102082. PubMed ID: 33096345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbrella and basket trials in oncology: ethical challenges.
    Strzebonska K; Waligora M
    BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker.
    Beckman RA; Antonijevic Z; Kalamegham R; Chen C
    Clin Pharmacol Ther; 2016 Dec; 100(6):617-625. PubMed ID: 27509351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment.
    Lengliné E; Peron J; Vanier A; Gueyffier F; Kouzan S; Dufour P; Guillot B; Blondon H; Clanet M; Cochat P; Degos F; Chevret S; Grande M; Putzolu J;
    Lancet Oncol; 2021 Oct; 22(10):e430-e434. PubMed ID: 34592192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period.
    Holliday EB; Ahmed AA; Yoo SK; Jagsi R; Hoffman KE
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):721-31. PubMed ID: 26104927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Cancer Trials With Immunomodulatory Agents: Personalizing Histology Agnostic Approaches.
    Baretti M; Azad NS
    Cancer J; 2019; 25(4):287-295. PubMed ID: 31335393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
    Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
    Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Efficacy of Cancer Therapies between Subgroups in Basket Trials.
    Palmer AC; Plana D; Sorger PK
    Cell Syst; 2020 Nov; 11(5):449-460.e2. PubMed ID: 33220857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basket Trials: Review of Current Practice and Innovations for Future Trials.
    Hobbs BP; Pestana RC; Zabor EC; Kaizer AM; Hong DS
    J Clin Oncol; 2022 Oct; 40(30):3520-3528. PubMed ID: 35537102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
    Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
    Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.
    De Feo G; D'Ambrosio F; Palmieri G; Perrone F; Ciliberto G
    Tumori; 2015; 101 Suppl 1():S33-7. PubMed ID: 27096270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.